헌팅턴병 : 주요 20개국 시장 예측
Epiomic Epidemiology Series: Huntington´s Disease Forecast in 20 Major Markets 2018-2028
상품코드 : 626778
리서치사 : Black Swan Analysis
발행일 : 2018년 04월
페이지 정보 : 영문 86 Pages
US $ 5,800 ₩ 6,851,000
PDF by E-mail (Single User License)
US $ 8,700 ₩ 10,277,000
PDF by E-mail (Site License/Up to 5 Users)
US $ 10,400 ₩ 12,285,000
PDF by E-mail (Corporate License)


한글목차

세계 주요 20개국의 헌팅턴병(HUNTINGTON'S DISEASE) 이환 상황을 조사했으며, 환자수 추이와 예측, 국가·연령층·성별·질환별 분석, 질환 개요, 위험인자, 질환의 진단과 예후, 주요 증상과 동반질환 등을 정리하여 전해드립니다.

1. 조사 대상국

2. 목차

LSH 18.04.25
영문 목차

영문목차

Black Swan Analysis Epiomic™ Epidemiology Forecast Report on Huntington's disease in 20 Major Markets

Huntington's disease (HD) is a rare hereditary genetic disorder of autosomal dominant nature. It is driven by a mutation in the HTT gene, coding for the protein huntingtin, which involves an abnormally large number of repeated sequences. It is a neurodegenerative disorder with onset at an average age of 40 years, leading to a varied range of motor, cognitive and psychiatric symptoms. The disease affects people in their most productive period of life and constitutes a serious and progressive burden to both the patients and their families.

This report provides the current prevalent population for Huntington's disease across 20 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, Poland, Netherlands, Ireland, Russia, Turkey, Japan, China, South Korea, India, Australia, Brazil, Mexico, Argentina) split by gender and 5-year age cohort. In addition to the current prevalence, the report provides an overview of the risk factors, diagnosis and prognosis of the disease, along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team at Black Swan, several features of Huntington's disease patients, as well as the main symptoms and comorbidities of the disease have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities of Huntington's disease include:

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world-class sources that deliver the most up-to-date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy

CONTENTS

LIST OF TABLES AND FIGURES

(주)글로벌인포메이션 02-2025-2992 koreainfo@gii.co.jp
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기